...
首页> 外文期刊>Journal of Traditional and Complementary Medicine >Evaluation of anti-inflammatory activity of selected medicinal plants used in Indian traditional medication system in?vitro as well as in?vivo
【24h】

Evaluation of anti-inflammatory activity of selected medicinal plants used in Indian traditional medication system in?vitro as well as in?vivo

机译:印度传统药物系统体外体内中使用的部分药用植物的抗炎活性评估

获取原文
           

摘要

The present study was carried out to evaluate in?vivo and in?vitro anti-inflammatory potential of selected medicinal plants used in Indian traditional medication. The sequentially extracted plant samples as, Cissus quadrangularis , Plumbago zeylanica , Terminalia bellarica and Terminalia chebula in water, ethanol and hexane were evaluated in-vitro for COX-1 and 2 inhibitory and antioxidant activities. The in?vivo anti-inflammatory activity of selected samples showing promising COX-2 inhibition was assessed using carrageenan and Phorbol Myristate Acetate (PMA) induced mice edema animal model. The results obtained reveals that most of the plants were found to inhibit COX-2 activity as compared to COX-1. It was observed that the extracts of T.?bellarica (73.34 %) and T.?chebula (74.81 %) showed significant COX-2 selective inhibition as compared to other samples. The ethanol extract of the selected plants demonstrated effective DPPH, OH and superoxide radical scavenging activity. In?vivo anti-inflammatory study shows that, T.?bellarica and T.?chebulla had a significant impact on inhibition of edema formation. The cytotoxicity evaluation study of ethanolic fraction of selected medicinal plants indicates that the selected samples have no effect on cell viability. HPTLC fingerprint of flavonoids of the selected samples was also prepared as a measure of quality control. The results obtained may be useful in strengthening the standardization of the selected botanicals. Moreover the selected plants can be considered as a resource for searching novel anti-inflammatory agents possessing COX-2 inhibition. Graphical abstract Display Omitted.
机译:本研究旨在评估印度传统药物中所选药用植物的体内和体外抗炎潜力。在体外评估了在水中,乙醇和己烷中顺序提取的植物样品,例如,Cissus quadrangularis,Plumbago zeylanica,Bellalia bellarica和Terminalia chebula,对COX-1和2的抑制和抗氧化活性进行了体外评估。使用角叉菜胶和醋酸肉豆蔻酸乙酸酯(PMA)诱导的小鼠水肿动物模型评估了显示出有希望的COX-2抑制作用的选定样品的体内抗炎活性。获得的结果表明,与COX-1相比,发现大多数植物抑制COX-2活性。观察到,与其他样品相比,贝氏锥虫(73.34%)和奇异球菌(74.81%)的提取物表现出显着的COX-2选择性抑制作用。所选植物的乙醇提取物表现出有效的DPPH,OH和超氧化物自由基清除活性。体内抗炎研究表明,贝拉氏杆菌和小球藻对抑制水肿形成有重要影响。所选药用植物乙醇部分的细胞毒性评估研究表明,所选样品对细胞活力没有影响。还制备了所选样品中类黄酮的HPTLC指纹,作为质量控制的一种手段。获得的结果可能有助于加强所选植物药的标准化。而且,所选择的植物可以被认为是寻找具有COX-2抑制作用的新型抗炎剂的资源。图形抽象显示被忽略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号